KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Aurora Cannabis (ACB) EPS (Weighted Average and Diluted) (2020 - 2025)

Aurora Cannabis has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at $0.02 for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 94.11% to $0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.45 through Dec 2025, down 19.87% year-over-year, with the annual reading at $0.03 for FY2025, 102.47% up from the prior year.
  • EPS (Weighted Average and Diluted) was $0.02 for Q4 2025 at Aurora Cannabis, down from $0.66 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $4.72 in Q1 2022 and troughed at -$0.85 in Q1 2021.
  • The 5-year median for EPS (Weighted Average and Diluted) is $0.08 (2023), against an average of $0.58.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 2155.08% in 2025 against a maximum downside of 94.11% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.38 in 2021, then skyrocketed by 752.63% to $2.48 in 2022, then tumbled by 97.98% to $0.05 in 2023, then surged by 630.17% to $0.37 in 2024, then crashed by 94.11% to $0.02 in 2025.
  • Per Business Quant, the three most recent readings for ACB's EPS (Weighted Average and Diluted) are $0.02 (Q4 2025), $0.66 (Q3 2025), and $0.19 (Q2 2025).